NCT04067791View on ClinicalTrials.gov

A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melatonin in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Prolonged-Release Melatonin

4.47 mg melatonin in a bi-layer prolonged-release capsule

DIETARY_SUPPLEMENT

Immediate-Release Melatonin

4.47 mg melatonin in a standard release bi-layer capsule

Trial Locations (1)

N6A 5R8

KGK Science Inc., London

Sponsors

Lead Sponsor

Pharmavite LLC

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Pharmavite LLC

INDUSTRY